BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 1965793)

  • 1. Autoimmune pancytopenia following allogeneic bone marrow transplantation.
    Klumpp TR; Caligiuri MA; Rabinowe SN; Soiffer RJ; Murray C; Ritz J
    Bone Marrow Transplant; 1990 Dec; 6(6):445-7. PubMed ID: 1965793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Graft-versus-leukemia reactions following bone marrow transplantation for chronic myeloid leukemia.
    Mackinnon S
    Prog Clin Biol Res; 1992; 377():113-25; discussion 126-7. PubMed ID: 1438407
    [No Abstract]   [Full Text] [Related]  

  • 3. Fatal autoimmune pancytopenia following bone marrow transplantation for aplastic anaemia.
    De Lord C; Marsh JC; Smith JG; Singer CR; Gordon-Smith EC
    Bone Marrow Transplant; 1996 Jul; 18(1):237-9. PubMed ID: 8832026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resolution of psoriasis after allogeneic bone marrow transplantation for chronic myelogenous leukemia: late complications of therapy.
    Adkins DR; Abidi MH; Brown RA; Khoury H; Goodnough LT; Vij R; Westervelt P; DiPersio JF
    Bone Marrow Transplant; 2000 Dec; 26(11):1239-41. PubMed ID: 11149740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Italian survey on allogeneic BMT for chronic myeloid leukaemia.
    Arcese W; Mandelli F; Papa G; Bacigalupo A; Van Lint MT; Lucarelli G; Galimberti P; Polchi P; Tura S; Bandini G
    Bone Marrow Transplant; 1989 Dec; 4 Suppl 4():90-1. PubMed ID: 2697445
    [No Abstract]   [Full Text] [Related]  

  • 6. Immune haemolytic anaemia following T cell-depleted allogeneic bone marrow transplantation for chronic myeloid leukaemia: association with leukaemic relapse and treatment with donor lymphocyte infusions.
    Cwynarski K; Goulding R; Pocock C; Dazzi F; Craddock C; Kaeda J; Olavarria E; Kanfer E; Apperley J; Lawler M; Goldman JM
    Bone Marrow Transplant; 2001 Sep; 28(6):581-6. PubMed ID: 11607771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidermolysis bullosa acquisita, a rare late complication of allogeneic bone marrow transplantation?
    Burger J; Gmür J; Bruckner-Tuderman L
    Bone Marrow Transplant; 1992 Feb; 9(2):139-41. PubMed ID: 1571712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unrelated allogeneic bone marrow transplantation using high-dose busulfan and cyclophosphamide (BU-CY) for the preparative regimen.
    Sahebi F; Copelan E; Crilley P; Bolwell B; Avalos B; Klein J; Territo M; Gajewski J
    Bone Marrow Transplant; 1996 May; 17(5):685-9. PubMed ID: 8733682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allogeneic bone marrow transplantation using unrelated marrow donors.
    Fay JW; Collins RH; Piñeiro L
    Bone Marrow Transplant; 1993; 11 Suppl 1():81-2. PubMed ID: 8448557
    [No Abstract]   [Full Text] [Related]  

  • 10. Resolution of psoriasis following allogeneic bone marrow transplantation for chronic myelogenous leukemia: case report and review of the literature.
    Kanamori H; Tanaka M; Kawaguchi H; Yamaji S; Fujimaki K; Tomita N; Fujisawa S; Ishigatsubo Y
    Am J Hematol; 2002 Sep; 71(1):41-4. PubMed ID: 12221673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular remission induced by fractionated dose-escalating donor leukocyte infusion without graft-versus-host disease in a patient with chronic myelogenous leukemia relapsed after allogeneic bone marrow transplantation.
    Inai K; Wano Y; Yamamoto S; Ikebata Y; Iwasaki H; Tsutani H; Naiki H; Ueda T
    Anticancer Res; 1999; 19(6C):5631-4. PubMed ID: 10697631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Very late relapse of chronic myelogenous leukemia after allogeneic bone marrow transplantation.
    Sekhri A; Liu D; Rasul M; Ahmed N; Ahmed T; Seiter K
    Leuk Res; 2009 Sep; 33(9):1291-3. PubMed ID: 19344950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Donor cell leukemia in a patient developing 11 months after an allogeneic bone marrow transplantation for chronic myeloid leukemia.
    Ataergin S; Arpaci F; Cetin T; Guran S; Yakicier C; Beyzadeoglu M; Ozet A
    Am J Hematol; 2006 May; 81(5):370-3. PubMed ID: 16628734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of tumor necrosis factor alpha in acute graft-versus-host disease and complications following allogeneic bone marrow transplantation.
    Holler E; Kolb HJ; Hintermeier-Knabe R; Mittermüller J; Thierfelder S; Kaul M; Wilmanns W
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1234-6. PubMed ID: 8442099
    [No Abstract]   [Full Text] [Related]  

  • 15. [Successful treatment of recurrent chronic myelogenous leukemia in allogeneic marrow transplant recipient with the donor leukocyte transfusion, without induction of acute graft-versus-host disease].
    Yamazaki H; Nakao S; Takamatsu H; Ito T; Ueda M; Shiobara S; Matsuda T
    Rinsho Ketsueki; 1995 Jul; 36(7):677-81. PubMed ID: 7563596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myeloid mixed chimerism is associated with relapse in bcr-abl positive patients after unmanipulated allogeneic bone marrow transplantation for chronic myelogenous leukemia.
    Román J; Serrano J; Jiménez A; Castillejo JA; Reina ML; González MG; Rodríguez MC; García I; Sánchez J; Maldonado J; Torres A
    Haematologica; 2000 Feb; 85(2):173-80. PubMed ID: 10681725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resolution of atopic dermatitis following allogeneic bone marrow transplantation for chronic myelogenous leukemia.
    Koharazawa H; Kanamori H; Takabayashi M; Yamaji S; Taguchi J; Fujimaki K; Ishigatsubo Y
    Bone Marrow Transplant; 2005 Jun; 35(12):1223-4. PubMed ID: 15880131
    [No Abstract]   [Full Text] [Related]  

  • 18. Immune escape from a graft-versus-leukemia effect may play a role in the relapse of myeloid leukemias following allogeneic bone marrow transplantation.
    Dermime S; Mavroudis D; Jiang YZ; Hensel N; Molldrem J; Barrett AJ
    Bone Marrow Transplant; 1997 May; 19(10):989-99. PubMed ID: 9169643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allogeneic peripheral blood and bone marrow stem cell transplantation for chronic myelogenous leukemia: single center study from Iran.
    Ghavamzadeh A; Iravani M; Jabehdar-Maralani P; Hajrasouliha A; Tavakoli S
    Haematologica; 2003 Apr; 88(4):ELT13. PubMed ID: 12681990
    [No Abstract]   [Full Text] [Related]  

  • 20. Neutropenias following allogeneic bone marrow transplantation: response to therapy with high-dose intravenous immunoglobulin.
    Khouri IF; Ippoliti C; Gajewski J; Przepiorka D; Champlin RE
    Am J Hematol; 1996 Aug; 52(4):313-5. PubMed ID: 8701951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.